GLP-1 is an FDA-approved drug to promote weight loss in people who are considered obese and/or overweight
The American Journal of Pathology, 178(1), 19-25
Low Blood Sugar Semaglutide can lower blood glucose, and the risk of hypoglycemia increases when it is combined with insulin or an insulin-releasing medicine such as a sulfonylurea
doi: 10.1186/s12886-025-03958-4 [DOI] [PMC free article] [PubMed] [Google Scholar] 6.Bartelt K, Swaminathan S, Joyce B, Allen S, Deckert J
Recently, two mechanisms involved in the gut-brain axis have attracted increasing attention due to their role in the pathogenesis and progression of PD, namely, disruption of the composition of microorganisms living in the intestine (intestinal microbiome) and dysfunction of enteroendocrine cells, accompanied by impaired signaling through the GLP-1R [60]